Life Sciences Market Research Report
Report Filter Reset All
Sort By Price
Published Date
Category
Publishers
Report Type
Continents
Regions
Global Besponsa Market Insights, Forecast to 2025
Besponsa is an antibody-drug conjugate used to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). The global Besponsa market i...
$3,900.00 22 May, 2019 | QYResearch
Global Besponsa Market Insights, Forecast to 2025
$3,900.00 | 22 May, 2019 | QYResearch
Besponsa is an antibody-drug conjugate used to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). The global Bespons...
Global Enasidenib Market Insights, Forecast to 2025
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) g...
$3,900.00 22 May, 2019 | QYResearch
Global Enasidenib Market Insights, Forecast to 2025
$3,900.00 | 22 May, 2019 | QYResearch
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase ...
Global Enasidenib Drugs Market Insights, Forecast to 2025
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) g...
$3,900.00 22 May, 2019 | QYResearch
Global Enasidenib Drugs Market Insights, Forecast to 2025
$3,900.00 | 22 May, 2019 | QYResearch
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase ...
Global Idhifa Market Insights, Forecast to 2025
Idhifa is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene,...
$3,900.00 22 May, 2019 | QYResearch
Global Idhifa Market Insights, Forecast to 2025
$3,900.00 | 22 May, 2019 | QYResearch
Idhifa is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (I...
Global Gemtuzumab Ozogamicin Market Insights, Forecast to 2025
Gemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to 2010. The ...
$3,900.00 22 May, 2019 | QYResearch
Global Gemtuzumab Ozogamicin Market Insights, Forecast to 2025
$3,900.00 | 22 May, 2019 | QYResearch
Gemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to ...
Global Gemtuzumab Ozogamicin Drugs Market Insights, Forecast to 2025
Gemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to 2010. The ...
$3,900.00 22 May, 2019 | QYResearch
Global Gemtuzumab Ozogamicin Drugs Market Insights, Forecast to 2025
$3,900.00 | 22 May, 2019 | QYResearch
Gemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to ...
Global Mylotarg Market Insights, Forecast to 2025
Mylotarg is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to 2010. The global Mylota...
$3,900.00 22 May, 2019 | QYResearch
Global Mylotarg Market Insights, Forecast to 2025
$3,900.00 | 22 May, 2019 | QYResearch
Mylotarg is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to 2010. The glo...
Global Midostaurin Market Insights, Forecast to 2025
Midostaurin is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML), myelodysplastic syndro...
$3,900.00 22 May, 2019 | QYResearch
Global Midostaurin Market Insights, Forecast to 2025
$3,900.00 | 22 May, 2019 | QYResearch
Midostaurin is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML), myelodysplas...
Global Midostaurin Drugs Market Insights, Forecast to 2025
Midostaurin is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML), myelodysplastic syndro...
$3,900.00 22 May, 2019 | QYResearch
Global Midostaurin Drugs Market Insights, Forecast to 2025
$3,900.00 | 22 May, 2019 | QYResearch
Midostaurin is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML), myelodysplas...
Global Ivosidenib Market Insights, Forecast to 2025
Ivosidenib is an experimental drug for treatment of cancer. It is a small molecule inhibitor of IDH1, which is mutated in several forms of cancer. The global...
$3,900.00 22 May, 2019 | QYResearch
Global Ivosidenib Market Insights, Forecast to 2025
$3,900.00 | 22 May, 2019 | QYResearch
Ivosidenib is an experimental drug for treatment of cancer. It is a small molecule inhibitor of IDH1, which is mutated in several forms of cancer. ...
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
